Malignancies associated with BRCA 1 and 2 includes all except
**Core Concept**
The BRCA1 and BRCA2 genes play a crucial role in maintaining genomic stability by repairing DNA damage through homologous recombination. Mutations in these genes are associated with an increased risk of developing certain malignancies due to impaired DNA repair mechanisms.
**Why the Correct Answer is Right**
The correct answer is related to the fact that BRCA1 and BRCA2 mutations are primarily associated with breast and ovarian cancer. This is because the BRCA1 gene is involved in the repair of double-strand breaks, while BRCA2 is involved in the repair of interstrand crosslinks. The loss of these functions leads to an increased risk of mutations in genes that regulate cell growth and division, ultimately resulting in cancer. Specifically, BRCA1 mutations are associated with an increased risk of triple-negative breast cancer, while BRCA2 mutations are associated with an increased risk of ovarian cancer.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because BRCA1 and BRCA2 mutations are not strongly associated with prostate cancer. While there is some evidence to suggest a link between BRCA2 mutations and prostate cancer, the relationship is not as clear-cut as it is with breast and ovarian cancer.
**Option B:** This option is incorrect because BRCA1 and BRCA2 mutations are not strongly associated with pancreatic cancer. While there is some evidence to suggest a link between BRCA2 mutations and pancreatic cancer, the relationship is not as well-established as it is with breast and ovarian cancer.
**Option C:** This option is incorrect because BRCA1 and BRCA2 mutations are not strongly associated with lung cancer. While there is some evidence to suggest a link between BRCA2 mutations and lung cancer, the relationship is not as clear-cut as it is with breast and ovarian cancer.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that while BRCA1 and BRCA2 mutations are associated with an increased risk of breast and ovarian cancer, not all individuals with these mutations will develop cancer. Additionally, not all individuals with breast or ovarian cancer have BRCA1 or BRCA2 mutations.
**Correct Answer: D**